Učitavanje...
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis
Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). COVID‐19 mainly causes damage to the lung, as well as other organs and systems such as the hearts, the immune system and so on. Although the pathogen...
Spremljeno u:
| Izdano u: | Cell Prolif |
|---|---|
| Glavni autori: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7645923/ https://ncbi.nlm.nih.gov/pubmed/33098357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12939 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|